Your browser is no longer supported. Please, upgrade your browser.
Settings
ESRX Express Scripts Holding Company daily Stock Chart
ESRX [NASD]
Express Scripts Holding Company
IndexS&P 500 P/E10.83 EPS (ttm)5.53 Insider Own0.30% Shs Outstand601.00M Perf Week0.22%
Market Cap35.98B Forward P/E7.78 EPS next Y7.70 Insider Trans-0.25% Shs Float598.49M Perf Month-0.25%
Income3.42B PEG0.91 EPS next Q1.71 Inst Own89.40% Short Float5.58% Perf Quarter-15.61%
Sales100.15B P/S0.36 EPS this Y51.40% Inst Trans1.20% Short Ratio6.40 Perf Half Y-21.34%
Book/sh26.49 P/B2.26 EPS next Y10.38% ROA6.70% Target Price65.88 Perf Year-19.49%
Cash/sh5.26 P/C11.37 EPS next 5Y11.93% ROE21.70% 52W Range57.80 - 80.02 Perf YTD-12.98%
Dividend- P/FCF7.38 EPS past 5Y16.40% ROI12.90% 52W High-25.19% Beta0.94
Dividend %- Quick Ratio0.60 Sales past 5Y16.80% Gross Margin8.60% 52W Low3.56% ATR1.19
Employees25600 Current Ratio0.70 Sales Q/Q-0.60% Oper. Margin5.20% RSI (14)38.84 Volatility1.50% 1.63%
OptionableYes Debt/Eq0.98 EPS Q/Q11.50% Profit Margin3.40% Rel Volume0.54 Prev Close60.15
ShortableYes LT Debt/Eq0.87 EarningsApr 24 AMC Payout0.00% Avg Volume5.22M Price59.86
Recom2.70 SMA20-1.65% SMA50-6.00% SMA200-13.89% Volume2,823,915 Change-0.48%
Apr-26-17Downgrade Edward Jones Buy → Hold
Apr-25-17Reiterated Mizuho Neutral $76 → $61
Mar-15-17Downgrade Wells Fargo Market Perform → Underperform
Nov-04-16Upgrade Deutsche Bank Sell → Hold $69 → $70
Aug-02-16Reiterated Mizuho Neutral $77 → $82
Jun-20-16Downgrade Morgan Stanley Equal-Weight → Underweight
Jun-16-16Initiated Bernstein Underperform
Jun-07-16Resumed BofA/Merrill Neutral
Apr-27-16Reiterated FBR Capital Mkt Perform $90 → $75
Mar-16-16Initiated Credit Suisse Outperform
Mar-01-16Downgrade Mizuho Buy → Neutral $77
Feb-22-16Downgrade Deutsche Bank Hold → Sell $93 → $61
Feb-18-16Reiterated Barclays Overweight $102 → $85
Feb-17-16Reiterated Maxim Group Buy $109 → $95
Jan-21-16Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-19-16Downgrade Leerink Partners Outperform → Mkt Perform
Jan-13-16Reiterated Mizuho Buy $101 → $93
Oct-05-15Reiterated Leerink Partners Outperform $105 → $95
Jul-30-15Reiterated RBC Capital Mkts Outperform $87 → $96
Jul-16-15Initiated Mizuho Buy $98 → $101
May-23-17 04:05PM  New Research Reports for Oracle, Chubb, AstraZeneca & Others Zacks
May-22-17 10:02AM  Amazon's Next Big Thing Should Make Pharmacies Very Scared Motley Fool
09:32AM  Mallinckrodt & Express Scripts: What Chanos Got Wrong Barrons.com
May-19-17 06:50PM  Short-seller criticizes 'murky alliance' between Mallinckrodt, Express Scripts American City Business Journals
08:36AM  Jim Chanos has a way to profit on the drug overpricing backlash and still hates Tesla MarketWatch
05:59AM  Hikma cuts revenue forecast on generic Advair delay; shares sink Reuters
May-18-17 05:29PM  Evaluating Amazon's Chances in the Pharma Industry Investopedia
05:19PM  Jim Chanos is shorting 2 drug stocks with a 'murky alliance' Yahoo Finance
04:24PM  Chanos on Mallinckrodt, Express Scripts, Tesla and China Bloomberg
04:06PM  Why Chanos Is Shorting Mallinckrodt and Express Scripts Bloomberg
09:00AM  Express Scripts Subsidiary to Join Walgreens Boots Alliance Development Group Purchasing Organization PR Newswire
May-17-17 07:35PM  Express Scripts targets workers comp market with myMatrixx buy American City Business Journals
04:00PM  Express Scripts and myMatrixx Combine To Offer Best-in-Class Pharmacy Services for Workers' Compensation Programs PR Newswire
12:20PM  Could Amazon be Express Scripts' next competitor? American City Business Journals
11:45AM  CVS shares slip after report Amazon's getting into pharmacy CNBC
08:15AM  Post Earnings Coverage as Humana's EPS Surged 38%; Adjusted Revenue Gained 4% Accesswire
May-10-17 12:36PM  Four-Minute Valuation Of Express Scripts Forbes
May-08-17 05:26PM  Express Scripts Holding Company to Present at an Upcoming Conference PR Newswire
04:35PM  Express Scripts launches drug discount subsidiary American City Business Journals
08:47AM  Express Scripts and Eli Lilly CEOs on lowering drug costs with Inside Rx CBS News Videos
08:15AM  Cross-Industry Partnership Reduces The Cost Of Popular Diabetes, Asthma And Other Brand Name Drugs PR Newswire
08:00AM  Debate Intensifies Over Express Scripts Future As Standalone PBM Forbes
May-07-17 12:03AM  [$$] Pricing row shines spotlight on US pharmacy benefit managers Financial Times
May-05-17 05:08PM  6 Stocks Young Warren Buffett Would Buy in 2017 GuruFocus.com
02:00PM  Express Scripts Recognized Among Most Diverse U.S. Companies by DiversityInc PR Newswire
May-04-17 05:00AM  Inside the Scorpion Room Where Drug Price Secrets Are Guarded Bloomberg
May-03-17 05:26PM  Yacktman Buys Troubled Express Scripts, Sells S&P 500 GuruFocus.com
08:02AM  As Insurers Shuffle PBMs, Aetna Looks At Closer Ties To CVS Forbes
May-02-17 09:41AM  Express Scripts Takes Heavy Fire From Anthem Motley Fool
May-01-17 01:07PM  How Trumps First 100 Days Affected the Healthcare Industry Motley Fool
Apr-29-17 12:06AM  [$$] No Easy Remedy for Express Scripts Stock Barrons.com
Apr-28-17 11:28PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Express Scripts Holding Company and Encourages Investors with Losses to Contact the Firm Business Wire
07:17PM  Lifshitz & Miller LLP Announces Investigation of AdvancePierre Foods Holdings, Inc., Akorn, Inc., AllianceMMA, Inc., Altisource Portfolio Solutions, DelTaco Restaurants, Inc., Express Scripts Holding Company, China Unicom (Hong Kong) Limited, and Global Eagle Entertainment Inc. PR Newswire
Apr-27-17 12:57PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Express Scripts Holding Company Business Wire
12:00PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Express Scripts Holding Company (ESRX) PR Newswire
07:19AM  Express Scripts stock surges on investor hopes for an Anthem reconciliation MarketWatch
Apr-26-17 03:23PM  [$$] Anthem Says ACA Payment Loss Could Cause 20% Premium Hike The Wall Street Journal
03:17PM  ETFs with exposure to Express Scripts Holding Co. : April 26, 2017 Capital Cube
02:23PM  Framework Investing Case Study: Avoiding The Express Scripts Falling Knife Forbes
01:57PM  Amid uncertainty, Anthem proceeds with 2018 Obamacare plans Reuters
10:37AM  Express Scripts stock surges 3% after Anthem says no final decision made about 2020 contract MarketWatch
09:27AM  Anthem says it hasn't ruled out any PBM, including Express Scripts Reuters
09:19AM  Express Scripts Whipsaws Amid Public Soap Opera With Anthem Bloomberg
06:00AM  A Secret Profit Formula Loved by Drug Middlemen Is at Risk Bloomberg
05:31AM  [$$] Express Scripts Stock Seen Reaching $88 Barrons.com
12:30AM  [$$] Express Scripts Faces a Future Without Its Biggest Customer The Wall Street Journal
12:28AM  [$$] Corporate Feud Exposes Big Profits on Drug Sales The Wall Street Journal
Apr-25-17 07:41PM  Edited Transcript of ESRX earnings conference call or presentation 25-Apr-17 12:30pm GMT Thomson Reuters StreetEvents -10.77%
06:50PM  [$$] Express Scripts Faces a Future Without Its Biggest Customer The Wall Street Journal
05:14PM  Caterpillar and Biogen jump; Express Scripts plunges Associated Press
04:49PM  What Happened in the Stock Market Today Motley Fool
04:26PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Express Scripts Holding Company and Advises Investors with Losses to Contact the Firm Business Wire
04:23PM  Express Scripts is airing dirty laundry in its nasty, very public Anthem divorce MarketWatch
04:10PM  Express Scripts Stock Sliding, Anthem Unlikely to Extend Agreement TheStreet.com
04:04PM  Express Scripts, Teva Pharmaceuticals Drop into Tuesdays 52-Week Low Club 24/7 Wall St.
03:21PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Express Scripts Holding Company Business Wire
12:49PM  Here's Why Express Scripts Holding Company Is Getting Beaten Up Today Motley Fool
12:23PM  PBM Meltdown! Express Scripts Plunges on Anthem Loss Investopedia
11:54AM  5 Things You Need to Know About Express Scripts Losing Anthem Motley Fool
11:50AM  Express Scripts expects to lose its largest client American City Business Journals
11:38AM  [$$] Corporate Feud Exposes Big Profits on Drug Sales The Wall Street Journal
11:10AM  Express Scripts Holding Co. :ESRX-US: Earnings Analysis: Q1, 2017 By the Numbers : April 25, 2017 Capital Cube
11:10AM  Express Scripts seeks cost cuts, M&A as it preps for Anthem loss Reuters
11:09AM  Express Scripts' Anthem Loss Goes Deeper Than Numbers Bloomberg
10:35AM  SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Express Scripts Holding Company and Encourages Investors with Losses to Contact the Firm Business Wire
10:30AM  Analysts Try to Defend Express Scripts After Anthem Contract Loss 24/7 Wall St.
10:26AM  Express Scripts seeks cost cuts, M&A as it preps for Anthem loss Reuters
08:52AM  Express Scripts (ESRX) Earnings Top in Q1, FY17 View Up Zacks
06:57AM  A huge pharma middleman just lost its biggest customer and it shows how drug pricing really works Business Insider
12:49AM  PRESS DIGEST - Wall Street Journal - April 25 Reuters
12:35AM  [$$] Express Scripts Says It Will Lose Anthem, Its Biggest Customer, in 2020 The Wall Street Journal
Apr-24-17 10:01PM  EXPRESS SCRIPTS ALERT: J&W Announces Investigation of Express Scripts; Expects to Lose Biggest Customer, Investors Encouraged to Contact Firm PR Newswire
06:53PM  INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Express Scripts Holding Company and Advises Investors with Losses to Contact the Firm Business Wire
06:51PM  Express Scripts expects to lose biggest customer after 2019 Associated Press
06:45PM  Express Scripts says likely to lose top client Anthem Reuters
06:36PM  One of pharma's biggest middlemen just lost a big customer  and it exposes how the industry works Business Insider
06:35PM  Express Scripts CEO: Would love nothing more than to keep Anthem as client CNBC
05:57PM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Express Scripts Holding Co. Investors Business Wire
05:56PM  [$$] Express Scripts Says It Will Lose Anthem in 2020 The Wall Street Journal
05:41PM  After-hours buzz: AA, ESRX, WHR & more CNBC
05:13PM  One of the biggest middlemen in the drug industry is losing its largest customer and the stock is tanking Business Insider
05:00PM  Express Scripts shares drop 11% as Anthem unlikely to renew contract MarketWatch
04:57PM  Express Scripts says Anthem unlikely to renew contract after 2019 Reuters
04:37PM  Express Scripts CEO on Anthem contract: Time to show inve... CNBC Videos
04:08PM  Express Scripts to Lose Top Client Anthem Amid Legal Dispute Bloomberg
04:06PM  Express Scripts provides update on Anthem partnership CNBC Videos
04:01PM  Express Scripts Announces 2017 First Quarter Results; Provides Update on Anthem Relationship and Visibility into Core PBM Business Excluding Contribution from Anthem, Coventry and Catamaran PR Newswire
10:40AM  T-Mobile and 4 More Top Companies Reporting Earnings After the Close on Monday 24/7 Wall St.
09:42AM  3 Healthcare Bargain Stocks You Can Buy Right Now Motley Fool
Apr-21-17 06:01PM  Top Research Reports for Today: VZ, KO, SBUX Zacks
Apr-19-17 09:37AM  Will Express Scripts (ESRX) Q1 Earnings Hold a Surprise? Zacks
Apr-17-17 09:21AM  3 Deeply Discounted Value Stocks on Sale This Spring Motley Fool
Apr-11-17 05:00PM  Express Scripts Holding Company Announces First Quarter 2017 Earnings Conference Call GlobeNewswire
Apr-10-17 08:25AM  Mallinckrodt faces lawsuit from Illinois city American City Business Journals
Apr-06-17 01:33PM  Blame Game Over High Drug Prices Escalates With New Ad Bloomberg
09:15AM  Express Scripts CEO Explains Drug Price Competition Bloomberg
08:05AM  Express Scripts CEO on the steps to stopping rising drug prices Fox Business Videos
Apr-04-17 07:45AM  Mylan Copes With New Lawsuit and EpiPen Recall (MYL) Investopedia
07:00AM  U.S. Workers' Compensation Prescription Drug Spending Decreased 7.6% in 2016 Through Cost-Savings Solutions, Improved Care for Injured Workers PR Newswire
Apr-03-17 03:58PM  Mylan hit with new class action lawsuit over EpiPen pricing Reuters
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States, Canada, and Europe. It operates in two segments, PBM and Other Business Operations. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; and Express Scripts SafeGuardRxSM, a suite of solutions targeting the medication classes that pose a budgetary threat to its clients. The Other Business Operations segment distributes pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides consulting services, such as design, implementation, and project management for pharmaceutical and biotechnology manufacturers to collect scientific evidence to guide the use of medicines. The company serves care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2016, it operated four automated dispensing home delivery pharmacies; one non-automated dispensing home delivery pharmacy; and one non-dispensing home delivery pharmacy, as well as various non-dispensing order processing and patient contact centers, specialty drug pharmacies, and fertility pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anderson Phyllis S.Sr. VP & Ch. Marketing OfficerMay 19Sale60.081,10066,08811,108May 23 04:03 PM
Mergenthaler FrankDirectorMay 05Option Exercise51.258,042412,11232,766May 09 04:08 PM
MAC MAHON THOMAS PDirectorMay 05Option Exercise51.258,042412,11259,623May 09 04:06 PM
Breen Maura CDirectorMay 05Option Exercise51.258,042412,11227,687May 09 04:03 PM
LAHOWCHIC NICHOLASDirectorApr 28Option Exercise51.252,682137,43930,459May 02 04:14 PM
Paz GeorgeDirectorMar 03Option Exercise49.50174,3868,631,2351,060,362Mar 07 04:32 PM
Houston ChristineExecutive VP & COOMar 03Option Exercise49.5010,742531,67566,427Mar 07 06:14 PM
Neville EverettSr VP-Supply Chain & SpecialtyMar 01Sale70.162,352165,0168,935Mar 02 04:29 PM
Neville EverettSr. VP, Sup. Chain & SpecialtyJan 03Sale69.411,12377,94712,712Jan 05 04:01 PM
Miller Steven BSr. VP & Chief Med. OfficerNov 09Option Exercise49.5021,7981,078,89256,615Nov 14 04:02 PM
Miller Steven BSr. VP & Chief Med. OfficerNov 09Sale75.0221,7981,635,35134,817Nov 14 04:02 PM
Anderson Phyllis S.Sr. VP & Ch. Marketing OfficerNov 09Sale74.7464247,9838,173Nov 14 04:01 PM
MYERS WOODROW A JRDirectorSep 14Option Exercise56.0312,036674,35125,788Sep 16 04:47 PM
MYERS WOODROW A JRDirectorSep 14Sale70.4012,036847,38313,752Sep 16 04:47 PM
McGinnis Christopher AVP, Controller & Ch. Acct. OffSep 12Sale70.771,785126,3243,170Sep 13 04:51 PM
Mergenthaler FrankDirectorMay 27Option Exercise30.834,748146,38126,677May 31 04:04 PM